- Professor Giuseppe Campiani got his Laurea in 1983 discussing a theses entitled “Studies on psychotropic agents. Synthesis and stereochemical characterizazion of cis-4,5-dihydro-4-hydrozy-5-phenyl(pmethoxyphenyl) pyrrolo[2,1-d][1,5]benzothiazepine”
In 1989 he got his PhD in Pharmaceutical Sciences at Siena University discussing a theses entitled “Chemical investigations on pyrrolo[2,1-c][1,4]benzothiazines and pirrolo[2,1-d][1,5]benzothiazepines as potent pharmacological tools”.
From 1990 to 1998 he worked as researcher at the Faculty of Pharmacy of Siena University, in the field of medicinal chemistry.
In the period 1992-1993 he was post doctoral fellow and visiting scientist at the Mayo Clinic of Jacksonville,
FL. He collaborated with Prof. Alan P. Kozikowski on the “Design and synthesis of heterocyclic compounds of pharmaceutical interest: synthesis of Huperzine A and its analogues”. During this period he was engaged
in the synthesis of the natural alkaloid Huperzine A and structural analogues within a project aimed at the development of potential therapeutic agents against Alzheimer’s Disease.
He also collaborated with Interneuron Pharmaceuticals for the industrial development of the natural product.
In the period 1994-1995, he was at Columbia University in the City of New York collaborating with Prof. Koji Nakanishi at the Department of Organic Chemistry. He was engaged in the development of a methodology for the study of amino acids present in the binding site of the natural product Phylanthotoxin at the nicotinic receptor, within a project focussed on the study of neurodegenerative diseases.
From 1998 to 2001 he was associate professor at the Faculty of Pharmacy of Salerno University.
In the period of 2000-2001 Prof. Campiani was Visiting Professor at the Trinity College in Dublin, Dept of Biochemistry.
Since 2002 he is full professor of Medicinal Chemistry at the Faculty of Pharmacy at Siena University.
Prof. Campiani is one of the founder and he is the director of the Discovery and Development
In the period of 2003-2008 he was the Italian representative in the management Committee of EU-COST Actions.
Since 2008 he is Director of Dipartimento Farmaco Chimico Tecnologico (DFCT)
He is the scientific coordinator of several research projects granted by the Italian Ministery of University, by Pharmaceutical Companies, and EU.
He is consultant of Sigma-Tau and NeuroSearch for CNS and malaria projects (Sigma-Tau is boosting into the market a new fixed-combination in collaboration with MMV).
His research activity consist of 109 publications in peer-reviewed international journals with a high IF, and 15 international patents.
- Exploration of chemistry and biology of naturally-occurring and synthetic organic molecules with therapeutic potential in neurodegenerative, neuropsychiatric, viral (HIV/HCV) and parasitic (malaria/leishmania) diseases is an important part of my group's research. These interests include target selection and the rational design of innovative drugs, the discovery of new synthetic methodologies and general strategies for synthesis, bioinformatics and the study of important structure-function relationships.